Model N’s Latest Enhancements Address Duplicate Discounts, Global Tender Management

Model N, a provider of revenue optimization and compliance, services unveiled its spring 2023 product release for life sciences and high-tech customers. This latest semi-annual launch offers new products and platform enhancements to help pharma, medical technology, and high-tech manufacturers augment revenue operations and strengthen compliance across the business.

A few highlights of the branded launch include:

340B “Vigilance” prevents duplicate discounts - Duplicate discounts are a challenge for today’s pharma manufacturers that are participating in the $44 billion federal 340B drug pricing program. Model N’s 340B branded solution can flag and manage prescriptions in order to prevent duplicate discounts before rebate payment.

Global tender management for increase supply chain visibility in Europe -As tendering is more widely adopted globally within life sciences, the company’s new capability within global tender management can help provide complete visibility into inventory commitments across the supply chain, which could assist companies in this sector with maintaining administrative compliance while mitigating the risk of over or under production.

“Given today’s changing global economy, we know how important it is for our customers to innovate and quickly deliver high-value products,” says Suresh Kannan, Model’s N’s chief product officer. “Model N’s market-driven spring 2023 release introduces new products and enhancements that provide customers with technology solutions they need to adapt quickly, make strategic decisions, and grow their revenue stream, so they can continue innovating for their customers.”